Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $42.74 Million |
|---|---|
| Enterprise Value | $42.30 Million |
| Earnings per Share | $2.37 |
| Beta | -5.44 |
| Outstanding Shares | 58,548,051 |
| P/E Ratio | -6.62 |
|---|---|
| PEG | 2.4 |
| Price to Sales | - |
| Price to Book Ratio | -0.73 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 19.67 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.17 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Rosc...